Citation Impact
Citing Papers
Hyperemesis gravidarum, a literature review
2005
Consequences of Phosphate Imbalance
1988
P450 Enzymes
1992
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
The 4‐Quinolone Antibiotics: Past, Present, and Future
1988
Mitochondrial and Immunoallergic Injury Increase Risk of Positive Drug Rechallenge After Drug-Induced Liver Injury
2010
Serotonin Syndrome in a Child Associated with Erythromycin and Sertraline
1999
Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective
1995
Adverse drug reactions: definitions, diagnosis, and management
2000 Standout
Endpoints and clinical trial design for nonalcoholic steatohepatitis
2011
Eaten alive: a history of macroautophagy
2010 Standout
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
The liver and lovastatin
2002
Drug-Induced Hepatotoxicity
2003 Standout
Hepatotoxicity of germander in mice
1994
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
2002 Standout
The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy
1998 Standout
Cell Death
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Pancreatic Adenocarcinoma
2014 Standout
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
On peptide bond formation, translocation, nascent protein progression and the regulatory properties of ribosomes
2003 StandoutNobel
Mitochondrial control of cell death
2000 Standout
Herbal Hepatotoxicity
2007
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Crohn's disease
2016 Standout
The Serotonin Syndrome
2005 Standout
Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon
2001
Drug-Related Adverse Events
2001
Microfluidic organs-on-chips
2014 Standout
Autophagy: from phenomenology to molecular understanding in less than a decade
2007 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
1990
Mechanisms of halothane toxicity: Novel insights
1993
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Ulcerative colitis
2016 Standout
Antibiotic-associated acute vanishing bile duct syndrome: A pattern associated with severe, prolonged, intrahepatic cholestasis
1994
Idiosyncratic drug hepatotoxicity
2005
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
2001
Oxidative stress, KLF6 and transforming growth factor-β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats
2003
The ChEMBL database in 2017
2016 Standout
Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older Adults
2010 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Risk of Pancreatic Adenocarcinoma in Patients With Hereditary Pancreatitis: A National Exhaustive Series
2008
Reliability of a Modified Medication Appropriateness Index in Ambulatory Older Persons
1997
Diclofenac Sodium
1988
Diclofenac‐induced hepatitis: case report and literature review
1994
Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis
2002
Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis
1997
Mechanism of Quinolone Action and Resistance
2014 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune Hepatitis
1993
Trastuzumab-Induced Hepatotoxicity: A Case Report
2013 Standout
Adverse Effects of Macrolide Antibacterials
1993
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions
1994
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Causality classification at pharmacovigilance centres in the european community
1992
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
1987
Criteria of drug-induced liver disorders
1990 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The mitochondrial permeability transition pore and its role in cell death
1999 Standout
Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions
1995
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Challenges in Systematic Reviews That Assess Treatment Harms
2005
Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450
1991
Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
1994
Inhibition of Macroautophagy Triggers Apoptosis
2005 Standout
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
Drug-induced liver disease
2000
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Autophagy as a Regulated Pathway of Cellular Degradation
2000 StandoutScience
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Gaby Danan being referenced
Recurrent jaundice caused by recurrent hyperemesis gravidarum.
1984
Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
1993 Standout
Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.
1981
Consensus meetings on: Causality assessment of drug-induced liver injury
1988
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
1993
[Definitions and assessment criteria of acute drug-induced hepatitis. Conclusions of an International Consensus Meeting].
1991
[Fulminating hepatitis in a woman taking glafenine and diclofenac].
1985
DOP071 Inflammatory bowel diseases: a new cardiovascular risk factor?
2014
[Drug-induced hemolytic anemia. Results of consensus conferences].
1988
[Drug-induced renal insufficiency. Results of consensus meetings].
1989
EEC Pharmacovigilance and the Pharmaceutical Industry: Common Market, Common Rules?
1992
[Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
1987
Pirprofen-induced fulminant hepatitis
1985
Prolonged cholestasis after troleandomycin-induced acute hepatitis
1987
Drug–Induced Hepatitis Associated With Anticytoplasmic Organelle Autoantibodies
1985
Pefloxacin kinetics in cirrhosis
1985
Micropuncture study of renal phosphorus transport in hypophosphatemic vitamin D resistant rickets mice
1977
[Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings].
1989